In 2020, Kathrin “Kat” Kajderowicz’s father passed away from lung cancer. Kajderowicz was in charge of her father’s health care for as long as she can remember. While he suffered from various cardiovascular issues for several years, it wasn’t until the beginning of the Covid-19 pandemic that he was diagnosed with late-stage metastatic small-cell lung… Continue reading A cool path to disease deceleration
Tag: Lung Cancer
Outdoor air pollution may increase non-lung cancer risk in older adults
Chronic exposure to fine particulate air pollutants (PM2.5) and nitrogen dioxide (NO2) may increase non-lung cancer risk in older adults, according to a new study. In a cohort study of millions of Medicare beneficiaries, the researchers found that exposures to PM2.5 and NO2 over a 10-year period increased the risk of developing colorectal and prostate… Continue reading Outdoor air pollution may increase non-lung cancer risk in older adults
Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer
The use of immune checkpoint inhibitors (ICIs) continues to transform the therapeutic landscape of non-small cell lung cancer . The importance of this cancer ‘macroenvironment can be deciphered by comprehensive analysis of peripheral blood immune cell subsets, has been demonstrated in several cutting-edge preclinical reports, and is corroborated by intriguing data emerging from ICI-treated patients… Continue reading Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer
Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review
Immune-related adverse events (irAEs) are toxicities resulting from use of immune checkpoint inhibitors (ICIs) These side effects persist in some patients despite withholding therapy and using immunosuppressive and immune-modulating agents . The most common ICIs delivered were pembrolizumab (24%) and nivolumabs (37%) Most patients (75%) had metastatic disease and the primary cancer site was melanoma… Continue reading Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review
Camrelizumab Plus Platinum-Based Chemotherapy for Patients With T3N2 NSCLC
This randomized clinical trial assesses the efficacy and safety of neoadjuvant camrelizumab plus chemotherapy vs chemotherapy alone for patients with resectable stage IIIA
FDA Approves Lonsurf Plus Avastin for Metastatic Colorectal Cancer
FDA approves combination of Lonsurf and Avastin for patients with metastatic colorectal cancer . Patients previously treated with chemotherapies, an anti-VEGF
Exciting Lung Cancer Advances from 2023
In honor of World Lung Cancer Day, we took a look back at some of the exciting progress being made in the space.
Error in Abstract
The Original Investigation titled “Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios,” published May 8, 2023, was corrected to change “higher eGFR” to “lower eGFR” in the second sentence of the Results section of the abstract.
